The final motion to stop the 'Pfizergate' Covid vaccine fraud case from being dismissed has been submitted to the judge
- The whistleblower in the case, Brook Jackson, provided the court documents and spoke to Becker News.
- In the lawsuit United States of America ex rel. Brook Jackson against the Pfizer contractor Ventavia Research Group, the whistleblower's lawsuit alleges, "payment was contingent upon the vaccine receiving emergency use authorization ('EUA') and that the FDA in making that decision was reliant upon the accuracy of the data produced in the clinical trials."
- "Clinical trial fraud is not only a sound basis for a FCA claim, it is also the basis for criminal charges," the motion adds.
Ventavia failed to report Serious Adverse Events to Pfizer and Icon
- On at least four occasions the vaccine concentrate was over-diluted, which directly affects potency and reduces potential side-effects.
- Ventavia's documentation practices were careless, sloppy, inaccurate, and many times falsified
Brook Jackson was given until October 27, 2022 to respond to the defendant's Motion to Dismiss the case, which cites the False Claims Act.
- "It's all up to the judge now," Jackson told Becker News, noting that there is now two options. "1
- He allows us to move forward with discovery. 2
- Dismissed."
No comments:
Post a Comment